UPDATE 3-U.S. FDA clears new Merck drug for hepatitis C

disease with higher cure rates and shorter courses of therapy for some patients. A similar medicine from Vertex Pharmaceuticals Inc (VRTX.O: Quote, Profile, Research) is poised to win FDA clearance later this month. Industry analysts predict sales of...